Keeping a Mounjaro Weight Loss Diary: What to Record, and What to Do with It

What does a Mounjaro diary actually help you decide?

This is the central question worth sitting with before you open a notebook or a spreadsheet. Tirzepatide treatment is not a static event: the licensed schedule starts at 2.5 mg and titrates upward, typically in four-week steps, based on how well you're tolerating the current dose and how your weight is responding. That titration process is inherently iterative, and a diary makes it legible.

Three real decisions hinge on what you record. First, whether side effects are transient or persistent — gastrointestinal symptoms like nausea, constipation, or reflux usually ease as your system adjusts, but a diary distinguishes between "rough for three days after injection day" and "still bad at day ten", which matters when you're deciding whether to contact your prescriber. Second, whether your appetite suppression is consistent across the week or fades noticeably before the next injection, that pattern is worth raising at your next clinical review. Third, how your weight trend looks beyond week-to-week noise. Scales vary with hydration, clothing and time of day; a diary logged at the same time under the same conditions gives you a moving average you can actually trust.

None of these decisions should be made in isolation from clinical support. The diary informs conversations; it doesn't replace them. If you're new to treatment, the Mounjaro treatment overview explains the licensed framework and what clinical assessment covers before you start.

What to log, and how often to log it

A question our prescribers hear most weeks is whether people need to weigh themselves daily. The honest answer: once a week is enough, and more frequent weighing can cause unnecessary anxiety from normal biological fluctuation. Log your weight the same morning, before eating, after using the bathroom. That consistency matters far more than precision.

Beyond the scales, the most clinically useful entries cover five things. Injection day and site (abdomen, thigh or upper arm) rotated to avoid tissue irritation. Side effects in plain language: when they started, how intense (a simple 1–5 scale is fine), and when they eased. Appetite and fullness cues, particularly whether your eating behaviour changed relative to the previous week. Energy levels and any changes to sleep, given that significant calorie restriction alongside the medicine can affect both. And anything you'd want to mention to your prescriber but might forget, a bout of diarrhoea severe enough to affect hydration, or a week where eating felt unusually difficult.

The eight-week progress guide breaks down what most people notice across the early titration period, which can help you contextualise your own entries rather than reading them in a vacuum.

Reading your diary: patterns worth spotting

Raw entries become genuinely useful when you look across them rather than day by day. A few patterns are worth actively looking for.

Weight plateaus are normal, particularly around the time a dose holds steady. If your diary shows three to four weeks of broadly stable weight at a given dose before a prescribed increase, that's expected. If it shows a plateau persisting for two or more months with no dose change pending, that's a reason to flag it with your prescriber rather than quietly abandoning the pen. If you want to understand what realistic progress looks like over time, reading through a Mounjaro diary from someone further along in treatment can give you a useful point of reference. Research reported in SURMOUNT-1, published in the New England Journal of Medicine, confirmed that weight loss on tirzepatide continues to accrue over 72 weeks, not all at once.

Side-effect patterns tell a different story from isolated incidents. If nausea spikes sharply on injection day but is gone by day two, that's a tolerable and common response. If it persists through day five and is accompanied by vomiting, that warrants a message to your clinical team rather than a wait-and-see approach. The NHS tirzepatide medicine page lists the recognised side-effect profile, which is a useful reference alongside your own notes.

Cost and commitment are worth tracking too, not obsessively, but honestly. Treatment pricing is one factor people revisit at dose increases; the Mounjaro pricing page covers what private treatment typically costs in the UK, including what a transparent price should include.

When your diary should prompt you to contact someone

A diary is partly a safety tool. Certain entries should prompt action rather than continued logging. Severe, persistent abdominal pain that radiates toward the back is one of them, the MHRA Drug Safety Update from January 2026 highlighted acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines, and that symptom pattern warrants urgent medical assessment rather than a wait until the next scheduled review.

Entries showing significant difficulty eating (not reduced appetite, but genuine inability to tolerate food or fluids) or signs of dehydration after a run of GI illness should also prompt contact. The same applies to any mood changes or thoughts of self-harm: these are recognised on the safety profile and should never be logged and left. Your prescriber and GP are the right contact points; for urgent concerns, NHS 111 or 999 as appropriate.

At nume, aftercare is available seven days a week. If an entry in your diary worries you, reaching our team is straightforward and there is no limit on how often you can use that support. Once you have a pattern of entries and a clearer picture of your progress, you can read more about how Mounjaro weight loss typically unfolds to set realistic expectations for the next stage, or explore what using this weight loss jab involves before checking your eligibility for continued treatment.